These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24576930)

  • 21. Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis.
    Rossignol M; Moride Y; Perreault S; Boivin JF; Ste-Marie LG; Robitaille Y; Poulin de Courval L; Fautrel B
    Int J Technol Assess Health Care; 2002; 18(3):597-610. PubMed ID: 12391952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].
    Hosoi T
    Clin Calcium; 2009 Jan; 19(1):11-8. PubMed ID: 19122260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
    Hagino H; Hashimoto J; Okano T; Katagiri H
    Clin Calcium; 2008 Aug; 18(8):1176-82. PubMed ID: 18677057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of primary osteoporosis in men].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.
    Boonen S; Dejaeger E; Vanderschueren D; Venken K; Bogaerts A; Verschueren S; Milisen K
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):765-85. PubMed ID: 19028356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
    Iwamoto J
    Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical decision and patient education of pharmacotherapy for osteoporosis].
    Hosoi T
    Nihon Rinsho; 2009 May; 67(5):909-13. PubMed ID: 19432108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
    Fukunaga M; Sone T
    Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update].
    Orimo H
    Clin Calcium; 2011 Dec; 21(12):123-43. PubMed ID: 22133832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of FRAX and future issues in women's health].
    Hashimoto K; Ishitani K; Ohta H
    Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Osteoporosis prevention and use of the new management guideline for osteoporosis].
    Ohta H
    Clin Calcium; 2008 Aug; 18(8):1096-103. PubMed ID: 18677046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Diagnosis and Treatment of Osteoporosis].
    Kageyama G
    Rinsho Byori; 2015 May; 63(5):570-9. PubMed ID: 26524896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness and limitation of FRAX in the practice of internal medicine].
    Hosoi T
    Clin Calcium; 2009 Dec; 19(12):1749-55. PubMed ID: 19949266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.